The molecular chaperone HSP90 is crucial for the stability of many oncogenic proteins, including transcription factors, cell-cycle regulators, BCR pathway components and tyrosine kinases, suggesting that the high expression of HSP90α isoform maintains increased oncogene levels/activities in DLBCL cells [15–17]. This evidence concerns the gene HSP90AA1 and diffuse large B-cell lymphoma.